Observed frequency % (n) | |||
---|---|---|---|
MRC dyspnoea score | |||
1/2 | 3–5 | ||
GOLD 3/4 (FEV1 ³50% predicted) | C (n = 31) | D (n = 192) | |
QMVC weakness | 25.8% (n = 8) | 36.5% (n = 70) | |
Reduced SMWT | 9.7% (n = 3) | 47.9% (n = 92) | |
GOLD 1/2 (FEV1 <50% predicted) | A (n = 39) | B (n = 71) | |
QMVC weakness | 25.6% (n = 10) | 29.6% (n = 21) | |
Reduced SMWT | 5.1% (n = 2) | 16.9% (n = 12) |